.@aditxt $ADTX Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk
finance.yahoo.com/news/aditxt-su…
#Cancer #investors
Aditxt, Inc.
56 posts
We are a biotech innovation company with a mission of prolonging life and enhancing its quality by improving the health of the immune system.
Joined August 2018
- Exciting news at Aditxt (NASDAQ: ADTX)! 🚀 We're thrilled to share that we’ve signed a definitive agreement to acquire @Evofem Biosciences, Inc., makers of Phexxi®—the only FDA-approved hormone-free contraceptive gel. Phexxi empowers women in a revolutionary way. This on-demand
- The #ADTX team has submitted 2 requests for EUA to #FDA for AditxtScore™ for #COVID-19. We need to move the conversation to protection status, not just infection status. businesswire.com/news/home/2022…
- Eazy Testing Inc. Becomes AditxtScore™ Channel Partner, to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring with its Walk-In, Concierge, and Pre-Flight Services aditxt.com/investor-relat…
- Join Aditxt’s (NASDAQ:ADTX) Fireside Chat Friday, Feb 21 @ 11:30 AM ET CEO Amro Albanna will provide company update including key developments across Adimune, Pearsanta, and upcoming initiatives. Submit Qs by Feb 20 5PM ET: [email protected] us06web.zoom.us/webinar/regist…
- 🌍 In South Sudan, girls are more likely to die in childbirth than finish school. 300K maternal deaths in 2020 @DFID_UK reports. @Evofem's Phexxi® leads in non-hormonal contraception, empowering women's reproductive health. lnkd.in/gvm543gD
- You don’t wear a car seat belt for protection when you’re not in a car…. Why daily birth control? Since 1960, that's been the norm, but every day isn't 'that day'. Meet Phexxi: The birth control revolution! Take charge only when needed - say goodbye to daily doses! Time for
00:00 - Thanks to @mariaaspan from @FortuneMagazine for speaking with Amro & Saundra from @Evofem about the recent announcement. We recognize Evofem's incredible potential, we're committed to ensuring its sustained success as a promising innovation, expanding accessibility to women
- A ‘bionic pancreas’ that combines an insulin pump and automated dosing software has been approved by the US Food and Drugs Administration (FDA) for use by people living with #TypeOne diabetes in the US. tinyurl.com/yv7nuh2e #Innovation
- Aditxt Secures CLIA Certification for AditxtScore™ Laboratory Operations in Richmond, VA, and Plans to Launch AditxtScore™ for COVID-19 as a Lab Developed Test (LDT) $ADTX #ADTX #covid19 #nasdaq #invest #stockmarket buff.ly/332nmMW
- Kudos to the team at @Cutiss_AG for their work on developing denovoSkin, a personalized human skin graft that can be bio-engineered in large quantities to grow with the patient’s healing skin. Via @DermTimesNow tinyurl.com/mtxt7995 #SkinGraft #Innovation
- Final Call to Join Our Investor Event Today! Amro Albanna will provide an overview of our plans for 2024 and the promising innovations showcasing our commitment to tackling complex health challenges. Don't miss this chance to be a part of our journey. Last chance to register
- The challenges impacting healthcare innovation in Europe, as articulated by @andrew_wrob in this article are not dissimilar from what has impacted innovation in the US. tinyurl.com/yhf4uhe3 #Healthcare #Innovation
- A research team led by Dr. Hasan Erbil Abaci of @Columbia University has been working on methods to make 3D engineered skin in the shape of complex body parts. Via @NIH. #Innovation







